Eleonora Francesca Spinazzi

Assistant Professor

Columbia University

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Eleonora Francesca Spinazzi is an Assistant Professor at Columbia University, United States. Her research focuses on neurodegenerative diseases, particularly Alzheimer's and gliomas, as well as acute ischemic stroke and advanced microelectrode technologies. Recent publications include studies on biomarkers in Alzheimer's disease, microvascular failure in stroke, and innovative drug delivery methods in glioblastoma.

Articles (9)

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (5)

Andrew Teich

Columbia University Columbia College

UNITED STATES

View details

Cheng-Chia Wu

Assistant Professor

Columbia University Irving Medical Center

UNITED STATES

View details

Zeljko Tomljanovic

Columbia University

UNITED STATES

View details

Petros Petridis

New York University

UNITED STATES

View details

Jeffrey Bruce

NewYork-Presbyterian Hospital/Columbia University Irving Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eleonora Francesca Spinazzi

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Alzheimer's disease CSF biomarkers correlate with early pathology and alterations in neuronal and glial gene expression.

Progressive microvascular failure in acute ischemic stroke: A systematic review, meta-analysis, and time-course analysis

No-Reflow Post-Recanalization in Acute Ischemic Stroke: Mechanisms, Measurements, and Molecular Markers

A Wireless, Mechanically Flexible, 25μm-Thick, 65,536-Channel Subdural Surface Recording and Stimulating Microelectrode Array with Integrated Antennas.

Chronic convection-enhanced delivery of topotecan for patients with recurrent glioblastoma: a first-in-patient, single-centre, single-arm, phase 1b trial.

An immune response characterizes early Alzheimer's disease pathology and subjective cognitive impairment in hydrocephalus biopsies.

The Sledgehammer in Precision Medicine: Dexamethasone and Immunotherapeutic Treatment of Glioma.

Deconvolution of cell type-specific drug responses in human tumor tissue with single-cell RNA-seq.

Convection Enhanced Delivery of Topotecan for Gliomas: A Single-Center Experience

Collaborators (5)

Andrew Teich

Cheng-Chia Wu

Zeljko Tomljanovic

Petros Petridis

Jeffrey Bruce

Make your next move.